DarioHealth Corp (OQ:DRIO)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 18, 2024 08:30 am ET
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health
Apr 10, 2024 08:30 am ET
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens
Apr 02, 2024 08:30 am ET
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - musculoskeletal and behavioral health
Mar 28, 2024 06:30 am ET
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the core B2B2C revenue increased.2023 B2B2C, employers and health plans recurring revenues increased 39% year over year as the core business continues to gain traction.Commercial revenues in 2023 generated majority of the revenue with B2B2C growing from 13% to 25% of total revenue from 2022 to 2023.GAAP operating expenses decreased by 11.2% sequentially from the third quarter of 2023.Non-GAAP operating expenses decreased 9.4% sequentially f
Mar 21, 2024 08:30 am ET
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
Company to host conference call and webcast at 8:30am ET
Feb 21, 2024 07:00 am ET
Feb 21, 2024 05:00 am ET
Jan 22, 2024 04:15 pm ET
Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will...
Jan 11, 2024 07:30 am ET
Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support
Dario's integrated solution to support improved whole health gains traction in public and labor market
Dec 05, 2023 07:30 am ET
National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee Health
New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pre-diabetes, hypertension and those taking a GLP-1 medication
Nov 29, 2023 10:00 am ET
Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension Offering
Nonprofit health plan expands services to better meet the healthcare needs of Californians by making it easier to enroll in lifestyle medicine programs at no additional cost
Nov 27, 2023 07:30 am ET
Dario Contracts with New Employer for Cardiometabolic Solution
Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization search for proven ways to change health behaviors
Nov 21, 2023 07:30 am ET
New Research Sheds Light on Mediators of Improved Outcomes in Dario Users
Two new analyses associate improved clinical and economic outcomes with use of Dario's digital health solution
Nov 13, 2023 07:30 am ET
Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose
New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1s
Nov 02, 2023 06:30 am ET
DarioHealth Reports Third Quarter 2023 Financial and Operating Results
Third quarter total revenue of $3.52 million compared to $6.6 million in the third quarter of 2022, impacted mainly by lower commercial strategic partners revenues in the quarter of $209,000 as compared to $3.1 million in Q3 2022. Third quarter 2023 commercial B2B2C revenues from monthly recurring revenues derived from employers and health plans is up 19.3% over third quarter 2022; nine months YTD up 57% over comparable period in 2022.Aetna on track to launch its Dario powered behavioral health platform in the first quarter of 2024, with multiple employers already committed to the platform.E
Nov 01, 2023 08:30 am ET
Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter
New connectivity expands Dario's advantage with consumer accessibility
Oct 30, 2023 08:30 am ET
DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd
Company to host conference call and webcast at 8:30am ET
Oct 17, 2023 08:30 am ET
New Research Shows 36% Reduction in 30-Day Hospital Readmission Rate for Dario Users with Type 2 Diabetes
New research demonstrates Dario's ability to reduce costs through lower utilization of expensive healthcare resources, and the winning of a prestigious gold ribbon award
Oct 05, 2023 08:30 am ET
Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm
Agreement names Dario as the preferred digital health provider for employer clients
Oct 03, 2023 08:30 am ET
DarioHealth to Host Investor Day on The Rise of Digital Health
In-person event scheduled for Tuesday, October 17, 2023, in New York
Sep 27, 2023 08:30 am ET
Dario Publishes New Research Demonstrating Clinically Significant Reductions in Depression Through its Digital Behavioral Health Programs
63% of members using the Dario platform saw significant reduction in depression and anxiety symptoms
Aug 02, 2023 08:30 am ET
Dario Introduces GLP-1 Behavior Change Program to Help Achieve Weight Loss Goals and Better Overall Health Outcomes
New program delivers whole health behavior change program to improve member health and deliver valuable insights to Dario's partners
Jul 26, 2023 08:30 am ET
New Research Shows $5,077 in Medical Costs Savings for Dario Users
Retrospective cohort study demonstrated significant reduction in medical costs for Dario users with Type 2 diabetes compared to non-users driven by a significant reduction in in-patient hospitalizations after one year
Jul 06, 2023 08:30 am ET
Dario Announces New Full Suite Employer Contract
New account anticipated to contribute to revenue in the second half of 2023
Jun 26, 2023 08:30 am ET
New Research Demonstrates 2.3 Point Reduction in HbA1c for Dario Digital Health Users with Baseline HbA1c Greater Than 9 points
Retrospective cohort study presented at the American Diabetes Association 83rd Scientific Sessions analyzed real-world data of Dario users against matched controls to demonstrate a greater reduction when compared to non-users who achieve a 1.8 point reduction with the usual standard of care
Jun 07, 2023 08:30 am ET
Dario Announces Two New Full Suite Employer Contracts
New accounts are anticipated to launch in the second half of 2023
Jun 01, 2023 08:30 am ET
Dario Management to Participate in the Stifel 2023 Virtual Cross Sector Insight Conference
NEW YORK, June 1, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that the Company will participate in the Stifel 2023 Virtual Cross Sector Insight Conference, which is being held June 6-7, 2023, at The Intercontinental in Boston, MA.
May 18, 2023 08:30 am ET
MedOne Launches Dario's Digital Health Solution to Help Members Improve Health with a Personalized Support
Dario's health solution now available to MedOne clients enrolled in Diabetes Care Path
May 11, 2023 06:30 am ET
DarioHealth Reports First Quarter Financial and Operating Results
Sequential quarterly growth in revenue to $7.07 millionGross profit margin improving to 44.8% sequentially in the first quarter of 2023, up from 40.1% of revenues in the fourth quarter of 2022Non-GAAP gross margin was 60.1% of revenues for the first quarter of 2023, up from 58.1% of revenues in the fourth quarter of 2022Reduced cash used in operating activities in the first quarter to only $4.76 millionFurther reduced net loss to $12.8 million in Q1 2023, versus $15.9 million in Q1 2022, and $12.6 million in Q4 2022Expanded strategic relationships by signing with Amwell and the first account
May 09, 2023 08:30 am ET
Sanofi research demonstrates 9.3% reduction in all-cause healthcare resource utilization rates, including 23.5% decrease in hospitalization for Dario users
Retrospective cohort study presented at ISPOR analyzed real-world data of users and non-users of a digital health solution
May 04, 2023 08:30 am ET
DarioHealth to Report First Quarter 2023 Results on Thursday, May 11th
Company to host conference call and webcast at 8:30am ET
May 02, 2023 08:30 am ET
DarioHealth Announces $14.3 Million Private Placement
Newly designated convertible preferred stock priced at the market under Nasdaq rules with significant participation by select members of leadership, the Board and existing investors
Apr 04, 2023 08:00 am ET
Digital Health Product Leader, Eitan Shay, Joins Dario as Chief Product Officer
Dario also appoints digital veteran, Arnaud Robert, to the role of Strategic Advisor to the Chief Executive Officer
Mar 27, 2023 08:00 am ET
Dario Selected as Digital Therapeutics Partner by a Top-Ten Digitally Enabled Pharmacy Benefits Manager
New agreement is the first contract resulting from strategic partnership with Sanofi
Mar 22, 2023 08:35 am ET
Dario Announces Strategic Partnership with Amwell to Expand Access to its Cardiometabolic Digital Therapeutic Solution
New agreement integrates Dario's cardiometabolic suite into Amwell's market leading digital care delivery enablement platform covering over 90 million lives
Mar 14, 2023 08:00 am ET
Dario Publishes New Research Demonstrating Digital Personalization of Pain Management with Adapted Machine Learning
Dario's musculoskeletal solution uses data from a biofeedback sensor to drive healthier behaviors and reduce pain
Mar 09, 2023 05:30 am ET
DarioHealth Reports Fourth Quarter and Record Revenue in Full-Year 2022 Financial and Operating Results
Continued to improve the financial profile of the CompanyFull-year 2022 revenue of $27.7 million increased 34.8% over $20.5 million in 2021, as B2B revenue growth more than offset managed reduction of B2C activitiesCommercial revenue contributed 59% to 2022 full-year total revenue, compared to 4% for the full-year 2021Gross margin was 40.1% of revenues for the fourth quarter of 2022, up from 9.1% of revenues for the fourth quarter of 2021Pro-forma gross margin was 58% of revenues for the fourth quarter of 2022, up from 22% of revenues for the fourth quarter of 202158.4% reduction in operatin
Feb 27, 2023 07:00 am ET
New Research from Dario Demonstrates Improved Clinical Outcomes in Two New Studies at the Advanced Technologies and Treatments for Diabetes 2023 Conference
Dario demonstrates the impact of targeted coaching interventions in a digital-first chronic care solution
Feb 24, 2023 07:00 am ET
DarioHealth to Participate in the Cowen 43rd Annual Healthcare Conference
NEW YORK, Feb. 24, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the Cowen 43nd Annual Healthcare Conference, which is being held March 6-8, 2023, at the Boston Marriott Copley Place in Boston, Massachusetts.
Feb 08, 2023 07:00 am ET
Dario Partners to Integrate Dexcom CGM Data
New integration will improve access to Dario's multi-chronic platform for more people living with diabetes
Feb 06, 2023 08:00 am ET
DarioHealth Announces Preliminary Fourth Quarter and Full Year 2022 Operating Results
Preliminary Results demonstrate success in B2C to B2B transformation
Jan 24, 2023 07:00 am ET
Dario Adds New Senior Vice President of Growth to Expanding Sales Team
Matt Alberico joins Dario to help manage expanding growth opportunities after successfully driving customer growth at Amazon Care, Cigna and Aetna
Jan 09, 2023 07:00 am ET
Dario Publishes New Research in Peer Reviewed Journal Demonstrating Improved Outcomes by Race and Ethnicity
New York, Jan. 9, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today the publication of new research in the peer-reviewed journal Applied Sciences demonstrating improved outcomes for users living with diabetes across different racial and ethnic groups. The research appears in the journal as part of the Special Issue: Digital Therapeutics Applications for Chronic Disease Management.
Jan 03, 2023 07:00 am ET
Dario Achieves Goal of 100 Business-to-Business Contracts in 2022
Northeast supermarket chain will deploy Dario's cardiometabolic suite in 2023
Dec 19, 2022 07:00 am ET
New Research Published in Peer Reviewed Journal Demonstrating Dario's Musculoskeletal Solution Reduces Back Pain
NEW YORK, Dec. 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced the publication of a new study in the peer-reviewed journal Frontiers in Physiology today demonstrating the effectiveness of the Company's musculoskeletal solution, which uses real-time biofeedback and behavior training to reduce back pain.
Dec 01, 2022 07:00 am ET
Two New Employers Join Dario Through Benefits Brokerage Partner
The new accounts originated through an existing relationship with a benefits brokerage and provide further validation of Dario's partnership Strategy.
Nov 16, 2022 07:00 am ET
Dario to Participate in Craig-Hallum and BTIG Digital Health
NEW YORK, Nov. 16, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that management will participate at the following conferences:
Nov 14, 2022 03:30 pm ET
DarioHealth Reports Third Quarter 2022 Financial and Operating Results
Third quarter 2022 revenues of $6.6 million increased 17.3% from $5.6 million in the third quarter of 2021 driven by growth in Business-to-Business (B2B) revenues. Nine-month year to date revenue totaled $20.8 million, a 44% increase over the first nine months of 2021.B2B revenues grew to 63.5% of total revenue for the quarter, up from 46% in the previous quarter30% reduction in net loss for the third quarter of 2022, compared to the third quarter of 2021 and 13.3% reduction from to the previous quarter85 signed B2B contracts to date with $61 million in total contract valueHigh market demand
Nov 09, 2022 07:00 am ET
DarioHealth to Report Third Quarter 2022 Results on Monday, November 14th
Company to host conference call and webcast at 8:30 am ET the next day
Oct 20, 2022 08:00 am ET
Dario Announces Two Employer Contracts for Full Suite of Digital Health Solutions
New 'jumbo' employer account represents increasing penetration of the Dario platform
Oct 13, 2022 08:00 am ET
Dario's Full Suite of Digital Solutions Selected by Midwestern City to Improve Employee Health
Dario to support City employees with integrated solutions addressing diabetes, hypertension, weight management, musculoskeletal and behavioral health in company's first government contract win
Sep 22, 2022 08:00 am ET
DarioHealth Publishes New Clinical Research Linking the Use of its Biofeedback Device to Reduced Back Pain
New research sheds light on the importance of training to drive healthier posture
Sep 20, 2022 08:00 am ET
DarioHealth Announces Two New Employer Contracts
New accounts demonstrate continued demand for integrated and holistic digital chronic condition management solutions
Aug 15, 2022 06:30 am ET
DarioHealth Reports Second Quarter 2022 Financial and Operating Results
Q2 revenue of 6.2 million, a 17.5% increase from the $5.3 million of the second quarter of 2021. Six-month year-to-date revenue totaled $14.2 million, a  60.8% increase over the first six months of 2021$55 million in total commercial contract value reflecting continued strong momentum across Business-to-Business-to-Consumer (B2B2C) channelsSelected by a national health plan as strategic behavioral health partner, providing reach to nearly ten million additional membersSanofi and other strategic partnerships gaining traction and expected to accelerate recurring revenue streams from employers
Aug 12, 2022 08:00 am ET
DarioHealth Presents New Research Demonstrating the Ability to Support People in Rural Areas and Deliver Lasting Health Improvements
The research examines Dario's ability to improve the health of members in rural areas compared to their urban counterparts and found the solution to be equally effective
Aug 11, 2022 08:00 am ET
DarioHealth Selected by National Health Plan to Enhance Mental Health and Well-Being for Members
Dario's digital behavioral health solution will help to improve access and navigation across mental health resources
Aug 10, 2022 08:00 am ET
DarioHealth to Report Second Quarter 2022 Results on Monday, August 15
Company to host conference call and webcast at 8:30 am ET
Aug 04, 2022 08:00 am ET
DarioHealth Presents New Research Demonstrating the Impact of a Digital Solution on Depression and Anxiety at the American Psychological Association Annual Convention
The studies underscore the value of Dario's integrated behavioral health solution to help more people connect to effective care that is right for their needs
Jul 21, 2022 08:00 am ET
DarioHealth Demonstrates Continued Growth in Multi-Chronic Contracts with Latest Addition of a National Employer for the Full Solution Suite
Demand for Dario's single approach to chronic condition management continues to show strong demand
Jun 21, 2022 08:17 am ET
DarioHealth Announces New Contract with a National Employer
Dario continues to grow footprint in the employer market
Jun 15, 2022 08:48 pm ET
Solera Health Adds DarioHealth to Its Cardiometabolic Network to Offer Hypertension Management Solutions
The addition of Dario's hypertension solution expands Solera's suite of best-in-class digital and community evidence-based health solutions
Jun 09, 2022 08:00 am ET
DarioHealth Secures $50 Million Dollar Non-Dilutive Credit Facility with OrbiMed
Investment from Elite Healthcare Fund Provides Validation, Access to Capital and Significant Runway to Execute on Strategic Operating Plan
Jun 03, 2022 08:00 am ET
DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association's 82nd Scientific Sessions
The studies demonstrated significant improvement in glucose control and reductions in blood pressure for users managing diabetes and hypertension and improvement in clinical measures for users with diabetes, stress and depression.
May 19, 2022 08:00 am ET
DarioHealth Announces Additional Commercial Contracts for its Digital Therapeutic Solutions
Two new B2B contracts reinforce Dario's position as an emerging leader in multi-chronic digital health
May 12, 2022 06:30 am ET
DarioHealth Reports Record Quarterly Revenues in its 2022 First Quarter
Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021
Apr 27, 2022 08:00 am ET
DarioHealth Presents New Clinical Research Demonstrating Improved Outcomes for Participants Using a Single Integrated Digital Solution to Manage Multiple Chronic Conditions
New research offers fresh evidence that a single digital therapeutics platform can improve outcomes for commonly co-occurring conditions
Apr 14, 2022 08:00 am ET
DarioHealth Announces Agreement with Health Plan Colorado Access
New health plan partnership improves access to digital health for historically underserved populations
Mar 23, 2022 08:00 am ET
DarioHealth Announces Additional New Employer Contracts
NEW YORK, March 23, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today two new employer agreements: first, with a U.S. based social platform employer and second, with a global health care company. The contracts are expected to launch in the second quarter of 2022.
Mar 22, 2022 06:30 am ET
DarioHealth Reports Fourth Quarter and Full Year 2021 Results and Operational Highlights
NEW YORK, March 22, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the fourth quarter and full year 2021 and provided a corporate and commercial update.
Mar 14, 2022 08:00 am ET
DarioHealth to Report Fourth Quarter and Full Year 2021 Results on Monday, March 21
NEW YORK, March 14, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and full year ended December 31, 2021 on Monday, March 21, 2022, after the close of trading. The company will host a conference call and webcast on Tuesday, March 22, at 8:30 am Eastern Time.
Mar 09, 2022 07:00 am ET
DarioHealth Announces Two New Contracts within the Employer and Provider Market
NEW YORK, March 9, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today new agreements with a regional employer and a regional provider. The contracts are expected to launch in the second quarter of 2022.
Mar 07, 2022 07:00 am ET
DarioHealth to Participate in the Cowen 42nd Annual Healthcare Conference
NEW YORK, March 7, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the Cowen 42nd Annual Healthcare Conference, which is being held virtually on March 7-9, 2022.
Mar 01, 2022 06:05 am ET
DarioHealth Enters into Strategic Agreement with Sanofi U.S.
NEW YORK, March 1, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced it has entered into a strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement, which is subject to certain contingencies, will help accelerate commercial adoption of Dario's full suite of digital therapeutics and drive the expansion of digital health solutions on the Dario platform.  
Mar 01, 2022 06:00 am ET
DarioHealth Announced Pricing of its Registered Direct Offering for Aggregate Proceeds of $40 Million Priced At-The-Market Under Nasdaq Rules
NEW YORK, March 1, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that on February 28, 2022 it entered into definitive agreements with institutional investors, including insurance companies located in Israel and primarily consisting of existing shareholders, in connection with a registered direct offering, providing for the issuance of an aggregate of approximately 5,342,013  shares of its common stock (or common stock equivalents in lieu thereof in the form of pre-funded warrants) at a price of $7.49 per share
Feb 09, 2022 07:00 am ET
DarioHealth Publishes Clinical Outcomes Demonstrating the Impact of Using a Single Digital Therapeutics Platform for Multiple Conditions
NEW YORK, Feb. 9, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced the publication of a retrospective, real-world study demonstrating the impact of managing blood pressure and diabetes together on the same digital platform in the leading peer-reviewed journal for digital medicine and health, the Journal of Medical Internet Research.
Feb 08, 2022 07:00 am ET
DarioHealth Announces Four New Employer Contracts
NEW YORK, Feb. 8, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced several new contracts to deliver its digital therapeutics solutions for four new employers. The new accounts are expected to launch during the first and second quarters of 2022.
Jan 20, 2022 07:00 am ET
DarioHealth Enters Agreement to Acquire Physimax, a Leading Provider of Validated Computer Vision for Musculoskeletal Health
NEW YORK, Jan. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market (the Company), announced it has entered into an agreement to purchase all of the right, title and interest in certain assets of Physimax Technologies Ltd. ("Physimax"), a leading provider of computer vision (CV) technology for Musculoskeletal (MSK) functional screening and predictive risk of injury assessment. Physimax's technology is currently in commercial use by NBA and NFL teams, the U.S. military and health care facilities specializing in orthopedic care. Th
Jan 19, 2022 06:00 am ET
DarioHealth Enters into Agreement with Large Regional Health Plan
NEW YORK, Jan. 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ-CM: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has contracted with a large regional health plan (the "Plan") to deliver its digital therapeutic solution for diabetes for eligible Medicaid members in and around the mid-Atlantic region. The contract is expected to contribute to revenue beginning in the second quarter of 2022.
Jan 18, 2022 07:00 am ET
DarioHealth to Host Investor Webinar on Navigating Emerging Digital Health Trends for Strategic Growth in 2022
NEW YORK, Jan. 18, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) a leader in the global digital therapeutics (DTx) market, today announced that it will host an investor webinar on navigating the emerging digital health trends in 2022 on Wednesday, January 19th at 8am ET.
Jan 06, 2022 07:00 am ET
DarioHealth Announces Two New Contracts within the Employer Market
NEW YORK, Jan. 6, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced two new contracts today to provide its highly personalized digital therapeutics beginning in the first quarter of 2022.
Dec 21, 2021 07:00 am ET
DarioHealth Selected as Exclusive Digital Therapeutics Provider to a Leading Benefits Brokerage
NEW YORK, Dec. 21, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced a new strategic partnership with a leading employer benefits brokerage (the "Partner") to sell its digital therapeutic solutions for diabetes, hypertension and musculoskeletal health as part of a new premier employee health benefits product for small businesses. The product will be made available to the Partner's more than 2,300 clients beginning in early 2022.
Dec 02, 2021 07:00 am ET
DarioHealth Announces Two New Contracts within the Employer and Provider Markets
NEW YORK, Dec. 2, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. The new clients include a regional employer contract for behavioral health, and a strategic partnership in the provider market that will allow Dario solutions to be sold through a network of practices across the United States. The two new contracts mark a key milestone for Dario, bringing its total signed clients to date to more than 50.
Nov 18, 2021 07:00 am ET
DarioHealth Announces Two New Employer Contracts
NEW YORK, Nov. 18, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two employers to provide its highly personalized digital therapeutic beginning in the first quarter of 2022.
Nov 15, 2021 04:00 pm ET
DarioHealth Reports Third Quarter 2021 Results and Operational Highlights
NEW YORK, Nov. 15, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter of 2021 and provided a corporate and commercial update.
Nov 15, 2021 05:40 am ET
DarioHealth Appoints Seasoned Health Care Executive Jerrod Helms as Chief Commercial Officer
NEW YORK, Nov. 15, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the Company appointed Jerrod Helms to the newly created role of Chief Commercial Officer (CCO) to support the rapid expansion of business in the employer, payer, provider and partnership markets that the company has seen over the last quarter and the anticipated acceleration into 2022. Mr. Helms will report to Rick Anderson, President and General Manager North America.
Nov 11, 2021 05:40 am ET
DarioHealth Announces Three New Contracts as Growth Continues to Accelerate Across the Employer and Provider Markets
NEW YORK, Nov. 11, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two new employers and a new provider partner channel to provide the Company's digital therapeutic solutions beginning in the first quarter of 2022.
Nov 08, 2021 05:40 am ET
DarioHealth to Report Third Quarter 2021 Results on Monday, November 15
NEW YORK, Nov. 8, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the third quarter ended September 30, 2021 on Monday, November 15, 2021, after the close of trading. The company will host a conference call and webcast on Tuesday, November 16, at 8:30 am Eastern Time.
Nov 05, 2021 07:00 am ET
DarioHealth to Participate in Upcoming Investor Conferences
NEW YORK, Nov. 5, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate at the following conferences:
Nov 03, 2021 06:51 am ET
DarioHealth Partners with National Group Benefits Platform
NEW YORK, Nov. 3, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today a new strategic partnership with a leading national benefits administrative platform ("Benefits Platform"), to provide its full suite of integrated digital therapeutic and health solutions to a wide range of employers, beginning in January of 2022.
Nov 01, 2021 06:40 am ET
DarioHealth Gathers Momentum in the Provider Market with Two New Contracts for Remote Patient Monitoring Services
NEW YORK, Nov. 1, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into contracts with two prominent regional providers in Hawaii and Georgia for its Remote Patient Monitoring (RPM) services.
Oct 27, 2021 06:40 am ET
DarioHealth joins Virgin Pulse partner network
NEW YORK, Oct. 27, 2021 /PRNewswire/ -- DarioHealth today announced it has partnered with Virgin Pulse, the leading global provider of digital and live health and wellbeing solutions, making its next-gen digital therapeutic and health solutions available for contract through Virgin Pulse to employers and health plans worldwide.
Oct 25, 2021 06:40 am ET
DarioHealth Announces Contract with a U.S. National Employer to Provide Its Full Multi-Condition Suite Digital Therapeutic Solutions
NEW YORK, Oct. 25, 2021 /PRNewswire/ -- DarioHealth Corp. ("Dario," "DarioHealth" or the "Company") (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into a contract with a U.S. national employer (the "Employer") for the Company's full multi-condition suite of chronic condition management solutions, including diabetes, pre-diabetes, hypertension, musculoskeletal, behavioral health, and digital employee assistance programs.  Enrollment of the Company's multi-condition suite of chronic condition management solutions is expected to beg
Oct 18, 2021 06:40 am ET
DarioHealth Unveils its Digital Musculoskeletal Solution Dario Move at HLTH 2021
BOSTON, Oct. 18, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of Dario Move, a new digital physical therapy solution to manage common musculoskeletal (MSK) conditions that drive significant costs for employers and health plans. The solution is being unveiled at HLTH 2021, one of the largest and most important conferences for health innovation, which is taking place in a hybrid format (in-person and virtual) from October 17-20 in Boston. 
Oct 14, 2021 06:30 am ET
DarioHealth Announces Agreement with Leading National Health Plan
NEW YORK, Oct. 14, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has entered into an agreement with one of the largest U.S. national health plans ("Plan") to offer its self-insured employer customers the Dario digital behavioral health solution as part of its behavioral health offering.  Initial members are expected on the platform in the fourth fiscal quarter of 2021, with additional rollout anticipated over the course of 2022. Dario will be paid a monthly fee for members that have access to the platform.
Oct 07, 2021 06:40 am ET
DarioHealth Announces Agreement with Global Employer for Metabolic and Musculoskeletal Health Solutions
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an agreement with a global company based in the United States ("Company") to provide its integrated digital health management solution for diabetes, hypertension, and musculoskeletal (MSK) health. The contract is expected to launch in the first quarter of 2022.
Sep 24, 2021 06:40 am ET
DarioHealth to Participate in the Cantor Fitzgerald Virtual Global Healthcare Conference
NEW YORK, Sept. 24, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in a fireside chat during the Cantor Fitzgerald Virtual Global Healthcare Conference, which is being held September 27-30, 2021.
Sep 17, 2021 06:40 am ET
DarioHealth Chief Medical Officer Dr. Omar Manejwala to Speak at American Health Insurance Plans National Conference on Medicare, Medicaid and Dual Eligibles
NEW YORK, Sept. 17, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Manejwala, will present at the annual American Health Insurance Plans National Conference on Medicare, Medicaid and Dual Eligibles being held virtually on September 22nd, 2021 at 12:45 p.m. EST.
Sep 09, 2021 06:40 am ET
DarioHealth Chosen by Northeast Regional Employer
Dario Continues to Expand its Employer Contracts Across Broad Range of Solutions
Sep 08, 2021 07:00 am ET
DarioHealth Selected by Another Employer for Behavioral Health Services
NEW YORK, Sept. 8, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its digital behavioral health platform to a casino resort company ("Casino Resort Company") in California. The contract is expected to contribute revenue beginning in the fourth quarter of 2021.
Aug 31, 2021 07:00 am ET
DarioHealth Chosen by Regional Primary Care Provider PeopleOne Health as its Digital Behavioral Health Partner
NEW YORK, Aug. 31, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has been selected by regional primary care provider PeopleOne Health to be the digital behavioral health solution of choice for patients beginning this September. This contract represents Dario's continuing growth in the provider market, leveraging its expanded product portfolio.
Aug 16, 2021 06:40 am ET
DarioHealth Reports Strong Second Quarter 2021 Results and Operational Highlights
NEW YORK, Aug. 16, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provided a corporate and commercial update.
Aug 12, 2021 08:30 am ET
DarioHealth Presents New Study Demonstrating Significant Clinical Impact of Personalized Digital Interventions Based on Real-Time Data
NEW YORK, Aug. 12, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced a new study at the American Association of Diabetes Care and Education Specialists (ADCES) annual conference demonstrating the impact of Dario's intelligent personalization platform.
Aug 09, 2021 08:30 am ET
DarioHealth to Report Second Quarter 2021 Results on Monday, August 16
NEW YORK, Aug. 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the second quarter ended June 30, 2021 on Monday, August 16, 2021, and host a conference call and webcast at 8:30 am Eastern Time.
Aug 04, 2021 08:30 am ET
DarioHealth Behavioral Health Solution Selected by National Employer
NEW YORK, Aug. 4, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as the digital behavioral health provider by a leading national professional services company.  
Jul 27, 2021 08:30 am ET
DarioHealth Launches Behavioral Health Solutions Globally in New Partnership with Workplace Options
NEW YORK, July 27, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced the launch of its digital behavioral health solution that now includes Workplace Options (WPO) services for its global users. WPO is the largest independent provider of integrated employee wellbeing solutions around the world.
Jul 20, 2021 08:30 am ET
DarioHealth Chosen to Provide Remote Patient Monitoring for Alabama Regional Medical Services
NEW YORK, July 20, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as a digital health provider by Alabama Regional Medical Services (ARMS), a Federally Qualified Health Center (FQHC) accredited by The Joint Commission and designated as a Primary Care Medical Home serving patients in Jefferson, Shelby, St. Clair, and Blount counties.
Jul 13, 2021 08:30 am ET
DarioHealth Chief Medical Officer Omar Manejwala, M.D., to Present on the Role of Digital Therapeutics in Post-Pandemic Healthcare at DTx Europe
NEW YORK, July 13, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present "Rebalancing: Digital Therapeutics in a Post-Pandemic Healthcare System" during the virtual conference DTx Europe on July 14th at 5:55 a.m. EST.
Jul 12, 2021 08:30 am ET
DarioHealth Expands Employer Footprint with Three New Contracts
NEW YORK, July 12, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced the launch of three new employer client contracts, including one global partnership, for the Company's new behavioral health solution powered by wayForward.  These contracts are for a fixed monthly fee based on the number of employees with access to the behavioral health platform and are expected to contribute to revenue beginning in the third quarter of 2021.
Jun 29, 2021 08:30 am ET
New Research from DarioHealth Expands Evidence that Personalized Interventions Impact Health Behaviors and Improve User Engagement
NEW YORK, June 29, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, presented new clinical research today at the American Diabetes Association (ADA) 81st Scientific Sessions, the premier diabetes conference for cutting-edge research and advances in diabetes care.
Jun 24, 2021 08:30 am ET
DarioHealth Remote Patient Monitoring Selected by Coastal Family Health Center to Improve Health of Patients with Hypertension
NEW YORK, June 24, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as digital health provider by Coastal Family Health Center, a local, non-profit healthcare network providing comprehensive primary care to patients across several underserved counties in and around the Mississippi Gulf Coast.
Jun 16, 2021 08:30 am ET
DarioHealth Expands Footprint in Musculoskeletal Sensor Technologies with the Upright GO S
NEW YORK, June 16, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of the Upright GO S, a new wearable sensor based on the company's pioneering biofeedback technologies to make better back health accessible to more people.
Jun 15, 2021 08:30 am ET
DarioHealth to be Added to Russell 2000® and 3000® Indexes
NEW YORK, June 15, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it is set to join the broad-market Russell 3000® Index and the small-cap Russell 2000® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective after the US equity markets open on Monday, June 28, 2021, according to a preliminary list of additions posted by FTSE Russell on Friday, June 4, 2021.
Jun 08, 2021 08:30 am ET
DarioHealth Announces Closing of wayForward Acquisition
NEW YORK, June 8, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the consummation of the previously announced acquisition of PsyInnovations, Inc. (dba wayForward) through the merger of PsyInnovations into DarioHealth's wholly-owned subsidiary, WF Merger Sub, Inc., which changed its name to PsyInnovations, Inc. in connection with the merger.  Under the Agreement and Plan of Merger, dated as of May 15, 2021, the Company paid, or will pay, aggregate consideration ("Merger Consideration") of (A) $6.0 million in ca
Feb 23, 2021 07:30 am ET
DarioHealth Announces Participation in the Cowen 41st Annual Healthcare Conference
NEW YORK, Feb. 23, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Cowen 41st Annual Health Care Conference, a virtual event taking place March 1-4, 2021.
Feb 19, 2021 07:30 am ET
DarioHealth to Participate in 10th Annual SVB Leerink Global Healthcare Conference
NEW YORK, Feb. 19, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Erez Raphael, Chief Executive Officer, is scheduled to participate and host investor meetings at the 10th Annual SVB Leerink Global Healthcare Conference that is scheduled to take place from February 24 to 26, 2021.
Jan 27, 2021 05:30 am ET
DarioHealth Announces Acquisition of Leading Digital Musculoskeletal Company Upright Technologies and $70 Million Financing
NEW YORK, Jan. 27, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the signing of a definitive agreement to acquire digital musculoskeletal (MSK) company Upright Technologies Ltd. in a stock transaction. Dario will be adding Upright's MSK solution to its digital therapeutic platform, which represents one of the most comprehensive multi-chronic condition platforms in the market with approximately 150,000 users. It brings together complementary companies with industry-leading consumer engagement and clinic
Jan 21, 2021 07:00 am ET
DarioHealth Announces Hiring of Leading Digital Health Innovator as Senior Vice President of Employer Sales
NEW YORK, Jan. 21, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. Mr. Chan will be responsible for leading growth initiatives in the self-insured employer market. Mr. Chan brings a unique perspective and strong understanding of the self-insured employer marketplace for digital health and DTx solutions.
Jan 13, 2021 07:00 am ET
Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Dr. Marilyn Ritholz and Dr. David Horwitz will join Chairman Eric Milledge on its Scientific Advisory Board (SAB), advancing Dario's technical leadership and helping to guide the development of its bold technology roadmap. Dr. Ritholz and Dr. Horwitz are recognized for their expertise in diabetes, metabolism, and behavioral health.
Jan 07, 2021 05:09 pm ET
Glancy Prongay & Murray LLP Announces Investigation on Behalf of DarioHealth Corp.
Glancy Prongay & Murray LLP (“GPM”) announces its investigation on behalf of DarioHealth Corp. (Nasdaq: DRIO) concerning the Company and its directors’ and officers’ possible violations of state laws.
Jan 07, 2021 07:00 am ET
DarioHealth Appoints Claudia Rimerman Kraut as Vice President of Broker and Consultant Partnerships
NEW YORK, January 7, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Claudia Rimerman Kraut as Vice President of Broker and Consultant Partnerships. In the newly created role, Ms. Kraut will be a senior member of the employer sales team and lead Dario's benefit consultant and alliance outreach as part of the self-insured employers and managed care sales organization. Ms. Kraut brings a strong combination of benefits, partnerships, and digital health experience, most recently as Director of Alliance
Jan 05, 2021 07:00 am ET
DarioHealth's Digital Therapeutics Solution Selected as Employee Health Benefit by Self-Insured, Fortune 500 Subsidiary
NEW YORK, Jan. 5, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its digital therapeutics solution to eligible employees of a subsidiary of a U.S. based Fortune 500 technology and engineering company. This agreement represents the first self-insured U.S. employer client secured through DarioHealth's previously announced partnership with Vitality Group.
Dec 22, 2020 07:00 am ET
DarioHealth Announces Agreement with Presbyterian Medical Services for Remote Patient Monitoring
NEW YORK, Dec. 22, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its remote patient monitoring (RPM) solution to Presbyterian Medical Services, one of the largest integrated healthcare systems in the State of New Mexico, effective January 1, 2021. The selection of DarioHealth followed a rigorous request for proposal (RFP) process in which Dario's RPM solution was evaluated alongside several other digital therapeutics platforms.  
Nov 24, 2020 07:00 am ET
DarioHealth's Digital Therapeutics Solution Selected as Employee Health Benefit by Self-Insured, Fortune 500 Company
NEW YORK, Nov. 24, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today that it has signed a contract to provide its digital therapeutics solution to eligible employees of a U.S.-based Fortune 500 technology company.
Nov 19, 2020 07:30 am ET
New DarioHealth Study Shows Increased Digital Therapeutics Engagement Leads to Marked Reduction in Blood Glucose, Lower High Readings among Type 2 Diabetic Seniors
NEW YORK, Nov. 19, 2020 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, presented results from a new clinical study of 940 members at the 20th Annual Diabetes Technology Society Meeting (DTS), which showed a marked reduction in the percentage of high blood glucose readings and in the average blood glucose readings in adults over the age of 65 years using Dario's digital therapeutics platform (Dario DTx).
Nov 12, 2020 05:30 am ET
DarioHealth Reports Third Quarter 2020 Results
NEW YORK, Nov. 12, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter 2020 and provided a corporate and commercial update.
Nov 04, 2020 07:30 am ET
DarioHealth to Report Financial Results for the Third Quarter 2020 on November 12
NEW YORK, Nov. 4, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it would release its second quarter ended September 30, 2020, financial results on Thursday, November 12, 2020, and host a conference call at 9:00 am Eastern Time.
Oct 13, 2020 09:05 am ET
DarioHealth Announces Inclusion of its Digital Therapeutics Platform in Vitality Group's New Gateway Flex Offering
NEW YORK, Oct. 13, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that Vitality Group has chosen the company's digital therapeutics solutions for inclusion in Vitality's new Gateway Flex offering.
Aug 07, 2020 08:30 am ET
DarioHealth to Report Financial Results for the Second Quarter 2020 Results on August 12
NEW YORK, Aug. 7, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial results on Wednesday, August 12, 2020, and host a conference call at 9:00am Eastern Time.
Jul 31, 2020 11:15 am ET
DarioHealth Announces $28.6 Million Private Placement
NEW YORK, July 31, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel. The company received aggregate gross proceeds of approximately $28.6 million, before deducting placement agent fees and other offering expenses.
Jul 20, 2020 08:30 am ET
DarioHealth Enters UK Remote Patient Monitoring (RPM) Market Through Agreement with Williams Medical
RHYMNEY, Wales and NEW YORK, July 20, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that the company has entered into a new strategic partnership with Williams Medical to make the DarioHealth Remote Patient Monitoring (RPM) digital therapeutics platform available to Healthcare Professionals (HCPs) across the United Kingdom and Ireland. Dario's turn-key RPM solution integrates the company's existing open platform, application technology, and the DarioEngage coaching platform, to allow Healthcare Professionals to monitor t
Jul 06, 2020 08:30 am ET
Dennis Matheis, President of Optima Health, a Multi-line Health Plan With More Than 850,000 Members and over 26,000 Providers, and Former President of Anthem Blue Cross and Blue Shield Central Region,
NEW YORK, July 6, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has appointed veteran health plan executive Dennis A. Matheis to its Board of Directors, effective July 2, 2020. Mr. Matheis brings to the Dario Board nearly 30 years of experience leading regional and national health care plans and related organizations. He currently serves as President of Optima Health, a division of Sentara Healthcare which has more than 850,000 members and a network of over 26,000 providers.
Jun 18, 2020 08:30 am ET
Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions
NEW YORK, June 18, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m. Eastern Time.
Jun 17, 2020 08:30 am ET
DarioHealth Announces Participation in the Virtual Going Digital: Behavioral Health Tech Summit
NEW YORK, June 17, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that Omar Manejwala, M.D., Chief Medical Officer, will present at the virtual Going Digital: Behavioral Tech Summit. DarioHealth is also a sponsor of the event.
Jun 15, 2020 08:30 am ET
DarioHealth Presents New Studies Demonstrating Sustained Improvements in Blood Glucose and Blood Pressure Control in Users with Diabetes and Hypertension at the American Diabetes Association's 80th Sc
NEW YORK, June 15, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) company, presented the results of two new studies at the American Diabetes Association's (ADA) 80th Scientific Sessions that showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases.
Jun 11, 2020 08:30 am ET
DarioHealth Announces Two Remote Patient Monitoring (RPM) Agreements and Commences Enrollment
NEW YORK, June 11, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has signed its first two remote patient monitoring (RPM) agreements. Remote patient monitoring will allow treating physicians to continue to be the primary source of medical advice for patients in between office visits, potentially preventing unnecessary and unplanned hospital visits. Dario's RPM product integrates the company's existing open platform, application technology, and the DarioEngage coaching platform to provide physicians
May 12, 2020 07:00 am ET
DarioHealth Reports First Quarter 2020 Results
NEW YORK, May 12, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter 2020 and provided a corporate and commercial update.
May 06, 2020 08:30 am ET
DarioHealth Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines
NEW YORK, May 6, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters including Dario's smartphone-connected metering device may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings
May 05, 2020 09:00 am ET
DarioHealth to Report Financial Results for the First Quarter 2020 Results on May 12
NEW YORK, May 5, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its first quarter ended March 31, 2020 financial results on Tuesday, May 12, 2020, and host a conference call at 8:30am Eastern Time.
May 04, 2020 08:30 am ET
DarioHealth Expands Offering to Include Behavioral Health
NEW YORK, May 4, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO),  a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include behavioral health coaching for stress, anxiety and loneliness, conditions which have recently escalated due to COVID-19 social distancing restrictions including "shelter-in-place" and "stay-at-home" orders.
Apr 29, 2020 08:30 am ET
DarioHealth Expands Remote Care Offering With Integration of Full-Service Telemedicine
NEW YORK, April 29, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in global digital therapeutics (DTx), announced today a new partnership with value-based telemedicine provider MediOrbis to expand Dario's existing service offering with a full suite of telemedicine capabilities for its 50,000 active users.
Mar 26, 2020 08:30 am ET
DarioHealth® Announces Key New Hires Expanding Its Management Depth in the Employer and Managed Care Markets
NEW YORK, March 26, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Omar Manejwala, M.D to the newly created position of Chief Medical Officer, and Barbara Stark as Senior Vice President and Head of Managed Markets. These two appointments provide decades of industry and clinical experience to the managed care and clinical support teams.
Mar 25, 2020 08:30 am ET
Dario Diabetes Management Is Recognized as a Leading Application for Children/Young People Self-managing Healthcare During COVID-19 Pandemic
NEW YORK, March 25, 2020 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a global digital therapeutics (DTx) innovator, announced today an endorsement from the U.K. based ORCHA, highlighting the Company's Diabetes Management Application as being suitable and safe for children and young people. In its recommendation, ORCHA mentioned the value of Dario's app in helping parents monitoring their child's diabetes information. The ORCHA team is part of NHS England's National Innovation Accelerator program and supports many NHS and local government organizations to drive the uptake of digital hea
Mar 24, 2020 08:30 am ET
DarioHealth Enters Into a Partnership With Vitality to Accelerate Penetration Into the Self-insured Employer Market
NEW YORK, March 24, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario") a pioneer in the global digital therapeutics market, announced today that it has entered into a partnership with Vitality Group, a global health and wellness company committed to making people healthier. Under the partnership, Vitality will integrate Dario's digital therapeutics for chronic conditions into its current wellness solution platform and co-market the Dario solution to Vitality's existing client base. In conjunction with the partnership, Dario granted Vitality warrants that will become exercisable
Mar 17, 2020 06:30 am ET
DarioHealth Reports Fourth Quarter and Year End 2019 Results
NEW YORK, March 17, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate and commercial update.
Nov 14, 2019 07:30 am ET
DarioHealth Corp. CEO Erez Raphael Invited to Participate in BTIG Digital Health 2019
CAESAREA, Israel and NEW YORK, Nov. 14, 2019 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Dario's CEO, Erez Raphael, will be participating in a panel discussion at BTIG Digital Health 2019: Industry Innovators on What's Next, on Wednesday, November 20, 2019.
Nov 12, 2019 07:30 am ET
Action Urgent Care Selects MyDario
SAN JOSE, California and NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of a Dario-powered digital diabetes program with Action Urgent Care.
Oct 28, 2019 06:29 am ET
DarioHealth Reports Results for Third Quarter 2019
NEW YORK and CAESAREA, Israel, Oct. 28, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported financial and operational results for the third quarter ended September 30, 2019.
Oct 22, 2019 08:03 am ET
DarioHealth Appoints Digital Therapeutics Pioneer Dr. Abigail Hirsch to Its Advisory Board to Support Commercial Strategy and Execution
CAESAREA, Israel and NEW YORK, Oct. 22, 2019 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, has appointed Dr. Abigail Hirsch to its Advisory Board where she will help guide commercial and Business-to-Business (B2B) efforts.
Oct 17, 2019 08:00 am ET
DarioHealth to Host Third Quarter 2019 Conference Call October 28, 2019
NEW YORK and CAESAREA, Israel, Oct. 17, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its third quarter 2019 results on Monday, October 28, and host a conference call the same morning at 9:00 am EDT.
Sep 23, 2019 08:00 am ET
DarioHealth CEO Erez Raphael Presents to Digital Therapeutics Leaders at DTx East 2019
NEW YORK and CAESAREA, Israel, Sept. 23, 2019 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth's Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019.
Sep 18, 2019 08:00 am ET
DarioHealth Awarded U.S. Patent for Optical Transmission of Data Between a Sensor and Smart Device
NEW YORK and CAESAREA, Israel, Sept. 18, 2019 /PRNewswire/ -- DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled "Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device." The patent will allow Dario to develop paired smartphone devices that can collect and analyze real-time medical data and provide immediate and highly detailed, personalized data reports to the user. Once collected, thi
Sep 11, 2019 07:30 am ET
Dance Biopharm Partners With DarioHealth to Expand Access to Digital Therapeutics Platform for Patients With Chronic Diseases
DURHAM, North Carolina and NEW YORK, Sept. 11, 2019 /PRNewswire/ -- Dance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, announced today it has formed a strategic alliance with DarioHealth Corp. "Dario" (Nasdaq: DRIO), a leading, global digital therapeutics company, to expand access to a personalized digital health management platform for patients with chronic diseases. Under the terms of the agreement, Dance Biopharm will integrate its gentle mist smart inhaler into DarioHealth's digital therapeutics platform to provid
Aug 28, 2019 08:30 am ET
DarioHealth to Present at RHK Capital Disruptive Growth Conference on Thursday, September 5th
NEW YORK and CAESAREA, Israel, Aug. 28, 2019 /PRNewswire/ -- Leading global digital therapeutics company DarioHealth Corp. (Nasdaq: DRIO) today announced that DarioHealth's Chief Executive Officer, Erez Raphael, will present to and meet with investors and analysts attending the RHK Capital Disruptive Growth Conference on Thursday, September 5, 2019 in New York City.
Aug 15, 2019 08:30 am ET
DarioHealth Announces Alliance with DigitalHealth.London As Part of the UK Israel Dangoor Health Initiative
NEW YORK and CAESAREA, Israel, Aug. 15, 2019 /PRNewswire/ -- DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London ("DH.L") as part of its UK Israel Dangoor Health Initiative (the "Initiative"), which aims to partner leading Israeli digital health companies with the UK National Health Service (NHS) to benefit patients.
Aug 13, 2019 06:20 am ET
DarioHealth Reports Results For Second Quarter 2019
NEW YORK and CAESAREA, Israel, Aug. 13, 2019 /PRNewswire/ -- 
Aug 12, 2019 08:30 am ET
DarioHealth® Clinical Study Data Shows the Dario Membership Program Assists Diabetes Patients in Achieving Pre-Diabetic Blood-Glucose Levels and Consistent In-Range Measurements
NEW YORK and CAESAREA, Israel, Aug. 12, 2019 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators ("AADE") conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario's digital therapeutics platform and dedicated one-on-one personal health coaching.
Aug 07, 2019 08:30 am ET
DarioHealth to Host Second Quarter 2019 Conference Call August 13, 2019
NEW YORK and CAESAREA, Israel, Aug. 7, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its second quarter 2019 results on Tuesday, August 13, and host a conference call the same morning at 9:00 am EDT.
Aug 06, 2019 07:47 am ET
DarioHealth to Present New Data at AADE Conference That Shows Improvement of Type 2 Diabetes Blood-glucose Levels Using MyDario™ App
NEW YORK and CAESAREA, Israel, Aug. 6, 2019 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to present the results of a new Dario app user study at the upcoming annual conference of the American Association of Diabetes Educators (AADE) in Houston, Texas on August 9-12, 2019.
Jul 30, 2019 07:47 am ET
DarioHealth Launches New Blood Pressure Monitoring System
NEW YORK and CAESAREA, Israel, July 30, 2019 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. The Dario Blood Pressure Monitoring System assists patients with hypertension and is a critical part of DarioHealth's strategy to go beyond diabetes to reach patients with a variety of chronic conditions.
Jul 25, 2019 08:03 am ET
DarioHealth USB Type C Connector for the European Android Market Is CE Marked
NEW YORK and CAESAREA, Israel, July 25, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today announced that its CE certificate covers a USB-C connector enabled version of the acclaimed Dario™ Blood Glucose Monitoring System. The USB-C connector is used to transfer power and communication signals between Android smart mobile devices and the Dario meter, and ensures that consumers, beginning with the Europe market region, will receive the same quality user experience with DarioHealth on the latest Android smart phone devices.
Jul 08, 2019 07:28 am ET
DarioHealth Granted 180-day Extension by Nasdaq to Regain Compliance With bid Price Rule
NEW YORK and CAESAREA, Israel, July 8, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced that on July 5, 2019, it received notification from Nasdaq that the Company has been granted an additional 180-day compliance period, or until December 23, 2019, to regain compliance with the minimum $1.00 bid price per share requirement of Nasdaq's Marketplace Rule 5550(a)(2) (the "Rule"). Nasdaq's determination to grant the additional 180-day compliance period was based on the Company meeting the continued listing requirement for the market valu
May 22, 2019 07:15 am ET
DarioHealth Corp. Announces Pricing of $7.2 Million Public Offering of Common Stock
CAESAREA, Israel, May 22, 2019 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced the pricing of an underwritten public offering of 4,855,341 shares of common stock at a price to the public of $0.60 per share and pre-funded warrants to purchase 7,175,525 shares of common stock at a price to the public of $0.5999 per pre-funded warrant for aggregate gross proceeds of approximately $7,200,000, before underwriting discounts and offering expenses. The pre-funded warrants have an exercise price of $0.0001 and
May 21, 2019 05:05 pm ET
DarioHealth Corp. Announces Commencement of Public Offering of Common Stock
CAESAREA, Israel, May 21, 2019 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced that it intends to offer and sell shares of common stock (or pre-funded warrants in lieu thereof) in an underwritten public offering. The proposed offering is subject to market and other conditions, as well as customary closing conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering.
May 13, 2019 06:20 am ET
DarioHealth Reports Record Results For First Quarter 2019
CAESAREA, Israel, May 13, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the first quarter ended March 31, 2019.
May 07, 2019 08:03 am ET
DarioHealth to Host First Quarter 2019 Conference Call May 13, 2019
NEW YORK and CAESAREA, Israel, May 7, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its first quarter 2019 results on Monday, May 13, and host a conference call the same morning at 9:00 am EDT.
May 03, 2019 08:03 am ET
DarioHealth Announces New Partnership With the American Diabetes Association
ARLINGTON, Virginia, NEW YORK and CAESAREA, Israel, May 3, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is partnering with the American Diabetes Association as a Living Red Sponsor of NYC - Step Out®: Walk to Stop Diabetes®.
Apr 30, 2019 08:03 am ET
DarioⓇ Becomes a Member of the Digital Therapeutics Alliance
WASHINGTON and CAESAREA, Israel, April 30, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is now a member of the Digital Therapeutics Alliance (DTA) (www.DTxAlliance.org).
Apr 10, 2019 08:03 am ET
Dario® Elevates Digital Therapeutics Capabilities by Further Enhancing Patient Experience
CAESAREA, Israel, April 10, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced the launch of a new version of its acclaimed Dario® system and DarioEngage™ platform.
Apr 01, 2019 08:03 am ET
DarioHealth Signs Leading Functional Medicine Clinic to DarioEngage™ Remote Digital Diabetes Platform
NEW YORK and CAESAREA, Israel, April 1, 2019 /PRNewswire/ -- Global #digitaltherapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced an agreement with Cupertino-based Auer Integrative Health's Functional Medicine and Chiropractic, a Silicon Valley medical clinic.
Mar 27, 2019 08:00 am ET
DarioHealth Partners With Glytec on Outpatient Diabetes Management
CAESAREA, Israel and WALTHAM, Massachusetts, March 27, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for use across the full continuum of care. The agreement allows DarioHealth's smart glucose meter (part of the Dario Blood Glucose Monitoring System) to transmit information to Glytec's Glucommander™ Outpatient software-as-a-medical-device.
Mar 25, 2019 06:15 am ET
DarioHealth Reports Fourth Quarter and Year End 2018 Record Results
CAESAREA, Israel, March 25, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the full-year ended on December 31, 2018.
Mar 20, 2019 08:30 am ET
DarioHealth Granted License by Health Canada to Sell Dario Smart Glucose Meters for Lightning® Connector Enabled iPhones
NEW YORK and CAESAREA, Israel, March 20, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), announced today the receipt of a license from Health Canada to sell its Dario™ Blood Glucose Monitoring System for Lightning power connector-enabled iPhone smart mobile devices.
Mar 18, 2019 09:00 am ET
DarioHealth to Host Fourth Quarter and Year End 2018 Conference Call March 25, 2019
NEW YORK and CAESAREA, Israel, March 18, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its fourth quarter and year-end 2018 results on Monday, March 25, and host a conference call the same morning at 9:00 am EDT.  
Jan 02, 2019 07:30 am ET
DarioHealth Signs National Distribution Deal in the U.S. With Better Living Now for Its Digital Health Products
NEW YORK and CAESAREA, Israel, Jan. 2, 2019 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement with Better Living Now (BLN), a leading national healthcare products provider, for distribution of the Dario® Blood Glucose Monitoring System and the DarioEngage digital health platform.
Dec 12, 2018 07:30 am ET
DarioHealth to Offer Diabetes Content and Coaching to Patients in Canada in Collaboration With LMC Healthcare, Canada's Largest Diabetes and Endocrinology Specialist Care Provider
CAESAREA, Israel, Dec. 12, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Toronto-based LMC Healthcare, Canada's largest specialist care provider in diabetes and endocrinology, will work with Dario who will provide digital content and coaching services  across Canada for patients with diabetes. LMC has 11 clinics and 19 clinical research sites that provide care to over 39,000 patients with diabetes in Canada.
Nov 14, 2018 07:00 am ET
DarioHealth's Diabetes Digital Health Solution Now Available at Best Buy
CAESAREA, Israel, Nov. 14, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that the Dario Blood Glucose Monitor has been included in Best Buy's growing portfolio of digital healthcare services and products.
Nov 13, 2018 05:30 am ET
DarioHealth Reports Third Quarter 2018 Results
NEW YORK and CAESAREA, Israel, Nov. 13, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the third quarter ended September 30, 2018.
Nov 12, 2018 07:00 am ET
DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains
CAESAREA, Israel, Nov. 12, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement for the rollout of a Digital Diabetes Education and Rewards Program, powered by Dario, to Giant Eagle's consumers through the pharmacy's 214 locations. Giant Eagle is ranked among the top 40 on Forbes magazine's list of largest private corporations in the U.S. It is one of the country's largest food retailers and distributors with approximately $8.9 billion in annual sales.
Nov 06, 2018 07:00 am ET
DarioHealth to Host Third Quarter 2018 Conference Call on November 13, 2018
NEW YORK and CAESAREA, Israel, Nov. 6, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its third quarter 2018 results on Tuesday, November 13, and host a conference call the same morning at 9:00am EDT. The Company will discuss its third quarter 2018 operating and financial results and its strategy and outlook for the remainder of 2018. The conference call will be hosted by Erez Raphael, Chief Executive Officer, Olivier Jarry, President and Chief Commercial Officer, a
Oct 25, 2018 08:00 am ET
DarioHealth Launches Integrated Diabetes Digital Health Solution Including Version 4.1 of Its Award-winning Dario App and DarioEngage Patient Coaching Platform
CAESAREA , Israel, Oct. 25, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch of version 4.1 of its award-winning Dario® App for the Dario Blood Glucose Monitoring System, part of the DarioHealth digital diabetes data management platform. The app, which is available both direct-to-consumer and through healthcare providers, is now fully integrated with the DarioEngage patient management and coaching platform, which serves the healthcare provider market.  
Oct 23, 2018 08:00 am ET
DarioHealth's Digital Health Blood Glucose Monitoring System Compatible With New iPhone XS and XS Max
CAESAREA, Israel, Oct. 23, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that its Dario LC™ Blood Glucose Monitoring System, which enables the use of the Dario App, is  compatible with the iPhone XS and iPhone XS Max, both of which were launched on September 21, 2018.
Oct 18, 2018 08:00 am ET
DarioHealth Appoints Glen D. Moller, Healthcare Executive, Investor and Former CEO of ArroHealth, to Its Board of Directors
CAESAREA, Israel, Oct. 18, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Glen Moller has joined the Company's Board of Directors. Mr. Moller is a highly regarded healthcare executive with a 25-year career leading healthcare and technology businesses, including a background in managed care and in technology enabled health services. He has held leadership positions in some of the largest healthcare companies in the U.S., including at Centene Corporation and Express Scripts Insurance
Sep 20, 2018 08:00 am ET
DarioHealth to Host Investor Conference Call on October 4, 2018
CAESAREA, Israel, Sept. 20, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will host a conference call to provide a business update for investors at 9:00am EDT on Thursday, October 4, 2018. The conference call will be hosted by Erez Raphael, Chief Executive Officer, Olivier Jarry, President and Chief Commercial Officer, Zvi Ben-David, Chief Financial Officer, and Yoav Shaked, Chairman of the Board. The live conference call can be accessed by dialing 877-407-8035 or 201-689-8035
Sep 14, 2018 08:00 am ET
DarioHealth Closes on $10,345,000 Through Private Placement Offering
CAESAREA, Israel, Sept. 14, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it has closed on a private placement offering with institutional and private investors for the sale of shares of the Company's common stock and shares of the Company's newly designated Series D convertible preferred stock.
Sep 05, 2018 07:00 am ET
DarioHealth Appoints Olivier Jarry, Former Head of Diabetes Care at Bayer and Executive at Novartis and Bristol-Myers-Squibb, as President and Chief Commercial Officer
CAESAREA, Israel, Sept. 5, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Olivier Jarry, a prominent global life sciences and consumer health executive, has joined the Company as President and Chief Commercial Officer. Mr. Jarry will be based in the U.S. and will lead DarioHealth's efforts relating to global revenue generation including B2B sales and data monetization. 
Aug 22, 2018 08:00 am ET
DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management
CAESAREA, Israel, Aug. 22, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has entered into an agreement with Attain Health, a provider of integrative health coaching for individuals living with cystic fibrosis, to pilot the DarioEngage platform for the management of cystic fibrosis related diabetes (CFRD). CFRD is a unique from of diabetes that occurs in a subset of the estimated 30,000 Americans and 70,000 people worldwide living with cystic fibrosis.
Aug 15, 2018 08:30 am ET
DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore
CAESAREA, Israel, Aug. 15, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it will exhibit the DarioEngage platform and its other digital health products at the American Association of Diabetes Educators (AADE) annual conference at booth #348 on August 17-20, 2018 in Baltimore, Maryland. In addition to providing product demos at the booth, a DarioEngage product exhibit will take place at 12:15 pm on Sunday, August 18 at the Exhibit Hall.
Aug 09, 2018 08:00 am ET
DarioHealth Reports Second Quarter 2018 Results
NEW YORK and CAESAREA, Israel, Aug. 9, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the second quarter ended June 30, 2018.
Aug 01, 2018 08:30 am ET
DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018
NEW YORK and CAESAREA, Israel, Aug. 1, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its second quarter 2018 results on Thursday, August 9th and host a conference call the same morning at 9:00am EDT. The Company will discuss its second quarter 2018 operating and financial results and its strategy and outlook for the remainder of 2018. The conference call will be hosted by Erez Raphael, Chief Executive Officer, and Zvi Ben-David, Chief Financial Officer. The live co
Jul 31, 2018 08:30 am ET
DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018
NEW YORK and CAESAREA, Israel, July 31, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its second quarter 2018 results on Thursday, August 9th and host a conference call the same morning at 9:00am EDT. The Company will discuss its second quarter 2018 operating and financial results and its strategy and outlook for the remainder of 2018. The conference call will be hosted by Erez Raphael, Chief Executive Officer, and Zvi Ben-David, Chief Financial Officer. The live c
Jul 25, 2018 08:00 am ET
DarioHealth Launches New Annual Membership & Product Enhancements to Promote Long-Term Use, Higher Levels of User Engagement, and Associated Sustainable Behavioral Changes
CAESAREA, Israel, July 25, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that following new data presented at the American Diabetes Association (ADA) on June 25, 2018 showing long-term sustainable clinical results, the Company has launched new product offerings and enhancements to promote the long-term use of its digital health platform.
Jul 12, 2018 08:00 am ET
DarioHealth CEO Erez Raphael's Interview Published in Research 2 Guidance
CAESAREA, Israel, July 12, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Research2Guidance, an analyst and strategic consulting company for the digital health industry, published an interview of DarioHealth CEO, Erez Raphael titled "Using real-time data to feed predictive care models for diabetes management." The interview covers topics including DarioHealth's position and strategy in the digital health market, as well as industry trends and a look at how users integrate digital h
Jul 09, 2018 08:00 am ET
DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board
CAESAREA, Israel, July 9, 2018 /PRNewswire/ --– DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today Yoav Shaked has joined the Company as Chairman of the Board. The Company's Chief Executive Officer, Erez Raphael shall continue serving on the board of directors and as CEO.  
Jun 25, 2018 08:00 am ET
DarioHealth Presents New Data at American Diabetes Association's 78th Scientific Sessions on June 25, 2018
CAESAREA, Israel, June 25, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported new data at the American Diabetes Association's (ADA) 78th Scientific Sessions which takes place in Orlando, Florida from June 22-26, 2018. On Monday June 25, 2018 from 12:00 pm – 1:00pm ET, DarioHealth's Head of Commercialization for North America, JC Muyl, is delivering three poster presentations.
Jun 21, 2018 08:00 am ET
DarioHealth to Deliver Three Poster Presentations With New Data at American Diabetes Association on June 25, 2018
NEW YORK and CAESAREA, Israel, June 21, 2018 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced JC Muyl, the Company's Head of Commercialization for North America, will deliver three poster presentations that will report new data at the American Diabetes Association's 78th Scientific Sessions on Monday June 25, 2018 from 12:00 pm – 1:00pm ET on Orlando, Florida.
Jun 19, 2018 08:00 am ET
DarioHealth Set to Join Russell Microcap® Index Effective June 25, 2018
NEW YORK and CAESAREA, Israel, June 19, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that its stock will be added to the Russell Microcap® Index, effective at market open on Monday, June 25, 2018. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell US Indexes primarily by objective, market-capitalization rankings and style attribut
Jun 07, 2018 08:00 am ET
DarioHealth Provides Update on Recently Launched iPhone 7, 8 and X Smart Glucose Meter in the U.S. Following FDA Clearance
NEW YORK and CAESAREA, Israel, June 7, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has experienced a successful launch of its iPhone® 7, 8 and X compatible Blood Glucose Monitoring System following FDA clearance.
May 21, 2018 04:05 pm ET
DarioHealth to Present at Chardan's Digital Health Conference
SAN FRANCISCO, May 21, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that Erez Raphael, Chairman and CEO of DarioHealth, will be delivering a presentation at Chardan's Digital Health Conference.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.